Psychiatry and Neurology, Neurology · Birmingham, AL
NPI
1083630305
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1717 6th Ave S
Birmingham, AL, 35233
Phone (800) 822-8816
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,095
114 services
Medicare patients, 2024
53
Average age 64
Drug cost, 2024
$3.2M
1,264 prescriptions
Company payments, 2025
$367
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John Rinker was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 48 times for 39 patients. In total John Rinker billed 114 services in 9 codes, and Medicare paid $5,095.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 48 | 39 | $9.82 | $471 |
| 99214 Office E&M - Established | Facility | 35 | 33 | $55.68 | $1,949 |
By year: 2022 $7,981 for 93 services; 2023 $8,586 for 109 services; 2024 $5,095 for 114 services.
Medicare prescription drug claims, 2024
In 2024, the drug John Rinker prescribed most often to Medicare patients was Gabapentin, with 111 prescriptions and refills. In total John Rinker wrote 1,264 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 111 | 119 | 20 | $1,704 |
| Baclofen Generic | 108 | 167 | 30 | $1,656 |
| Kesimpta Pen Ofatumumab | 66 | 66 | Under 11 | $591K |
| Clonazepam Generic | 56 | 64 | Under 11 | $287 |
| Fluoxetine Hcl Generic | 52 | 68 | Under 11 | $1,415 |
| Dalfampridine Er Dalfampridine | 48 | 50 | Under 11 | $27K |
| Topiramate Generic | 47 | 59 | Under 11 | $478 |
| Dimethyl Fumarate Generic | 43 | 53 | Under 11 | $111K |
| Rebif Interferon Beta-1a/Albumin | 39 | 39 | Under 11 | $396K |
| Pregabalin Generic | 26 | 36 | Under 11 | $882 |
| Trazodone Hcl Generic | 25 | 39 | Under 11 | $142 |
| Betaseron Interferon Beta-1b | 25 | 25 | Under 11 | $223K |
| Teriflunomide Generic | 25 | 25 | Under 11 | $53K |
| Tecfidera Dimethyl Fumarate | 24 | 24 | Under 11 | $215K |
| Tizanidine Hcl Generic | 24 | 40 | Under 11 | $439 |
Brand drugs: 286 claims; generic drugs: 978 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John Rinker $367 ($367 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genentech USA, Inc. with $217.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.